Case Study 1: Breaking the Steroid Cycle in Pediatric Atopic Dermatitis

In this pediatric atopic dermatitis case, a 7-year-old with rebound flares after hydrocortisone use and parental steroid concerns is ideal for a topical PDE4 inhibitor like roflumilast. Experts highlight its role in breaking the steroid cycle. Dr. Golant notes its rapid itch relief and sustained control, offering a non-steroidal option safe for long-term use. Dr. Eichenfield details a balanced approach: validating steroid fears while educating that rebounds are often disease persistence, not topical steroid withdrawal (which is rare in children). The goal is providing effective intervention to minimize disease impact on sleep and quality of life, leveraging clinical trial data showing efficacy in high BSA for informed, confident first-line decisions.